In ophthalmology, thyroid-associated ophthalmopathy (TAO) is a prevalent condition that lowers patients' quality of life. Eyelid retraction, proptosis, strabismus, compensatory head posture, and restricted eye movement are some of its key clinical symptoms. A TAO patient-specific Graves' ophthalmopathy quality of life questionnaire (GO-QOL), created in 1998 by Terwee has been proven to be reliable and valid. The European Group on Graves' Orbitopathy (EUGOGO) supports GO-QOL, which has been used extensively. According to a study by Jellema et al [10] utilising GO-QOL to compare preoperative and postoperative quality of life in strabismus patients with TAO, strabismus surgery can dramatically enhance patients' quality of life. But we discovered that up to 16 patients (among a total of 28 patients) received orbital decompression prior to strabismus surgery in the research. Strabismus may result with TAO orbital decompression, making strabismus surgery more difficult and ineffective. As a result, TAO orbital decompression may have an impact on patients' quality of life after strabismus surgery. The quality of life improvements in the patients following TAO strabismus surgery did not significantly differ between the groups who underwent orbital decompression and those who did not. There is currently no study to assess how strabismus surgery affects individuals with TAO who did not require orbital decompression in terms of quality of life. Therefore, the goal of the current study was to examine how strabismus surgery affected patients' quality of life who had quiescent strabismus. The First Affiliated Hospital of Guangxi Medical University's Ethics Committee accepted the current prospective case-series investigation, which adhered to the Declaration of Helsinki's guidelines. The patients who were enrolled in the study and their families were told of its relevance and purpose, and a signed informed consent form was used to get their consent. In this study, strabismus patients with TAO who were admitted to the Guangxi Medical University's First Affiliated Hospital between October 2011 and April 2016 were selected, and outpatient follow-up was carried out. In June 2016, the outpatient follow-up came to an end. (1) The diagnosis of TAO in this investigation was made using the diagnostic criteria suggested by Bartley et al in 1995 [16]. (2) The preoperative control of thyroid function was normal: Endocrinologists confirmed that the thyroid function (TT3, TT4, FT3, FT4) was normal in all included subjects. Patients with restrictive strabismus caused by TAO should have vertical strabismus greater than or equal to 10 and/or horizontal strabismus greater than or equal to 15. (3) In accordance with the circumstances of ocular inflammation [17] [18], CAS 3 was defined as inflammatory quiescence with stable strabismus for 3 months based on the method. There is no need for hyperthyroidism medication, and there is no recurrence of hyperthyroidism before strabismus surgery. suggested by EUGOGO. (4) The extraocular muscle was enlarged in the preoperative MRI; (5) the follow-up period was less than 6 weeks; and (6) the medical record was full. Exclusion standards: The following factors should be taken into consideration: (1) the patient had restrictive strabismus that was not brought on by TAO; (2) the patient had a history of orbital, extraocular muscle, and eyelid surgery; (3) the follow-up period was less than six weeks; (4) the medical record was lacking; and (5) the patient had a history of mental disorders, had taken medication that could lead to mental disorders, or had trouble following directions. Each patient's sex, age, clinical information, and outcomes from laboratory tests were gathered. Every subject got a standard orbital MRI scan. Prior to the procedure, the ocular alignment with distance fixation (5 m) was measured for 6 weeks after the surgery.Submit manuscript at www.walshmedicalmedia.com/submissions/eye-diseases-disorders.html or send as an e-mail attachment to eyedisorders[at]longdomjournal[dot]org